GMI

Targeted therapy with antineoplastons A10 and AS2-1 of high-grade, recurrent, and progressive brainstem glioma is an effective treatment (relative to conventional treatment)).


Comments

Leave a Reply

Your email address will not be published. Required fields are marked *